NRX Pharmaceuticals Inc (NRXP) Company Profile & Statistics

NRX Pharmaceuticals Inc
NRXP
(Nasdaq - US)
N/A
4.07
+0.53 (+14.97%)
in:usd•As of: May 20, 2024 15:59 UTC -4
Open
3.51
High
4.14
Low
3.51

About NRX Pharmaceuticals Inc

CEO

Stephen H. Willard

Headquarters

1201 orange street, suite 600

wilmington, de 19801, united states

Auditor

Salberg & Company, P.A.

Employees

N/A

Share Holders

Website

www.nrxpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

NRX Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	43.55M
Enterprise Value	49.01M
Enterprise Value/EBITDA (ttm)	-2.01
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	488.18%
Return on Assets (ttm)	-260.31%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-24.40M
Net Income Avi to Common (ttm)	-25.65M
Diluted EPS (ttm)	-3.14

Share Statistics

Beta (5Y Monthly)	1.15
52-Week Change	-40.58%
S&P500 52-Week Change	26.61%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	10.70M
Dividend Yield	0.00%
Float ⁴	8.45M
% Held by Insiders	21.06%
% Held by Institutions	4.27%

Balance Sheet

Total Cash (mrq)	1.32M
Total Cash Per Share (mrq)	0.12
Total Debt (mrq)	6.78M
Total Debt/Equity (mrq)	-44.99%
Current Ratio (mrq)	0.18%
Quick Ratio (mrq)	0.18%
Book Value Per Share (mrq)	-1.54

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.41
Free Cash Flow (ytd)	-3.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NRX Pharmaceuticals Inc

Trade With A Regulated Broker